Resihance (Regorafenib) – 40 Mg

Last Updated on 08/10/2025

Resihance (Regorafenib) – 40 Mg: What It Is?

Resihance (Regorafenib) 40 Mg is a cutting-edge targeted therapy for the treatment of specific cancers, such as metastatic colorectal cancer, gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma.

It belongs to a class of medications known as tyrosine kinase inhibitors, which function by inhibiting certain proteins that stimulate cancer cell proliferation and the growth of new blood vessels that supply tumors.

Working Of Resihance 40 Mg

Resihance 40 Mg (Regorafenib) targets and inhibits numerous protein kinases, which are important in colon cancer cell growth and distribution.

These proteins are essential for a variety of physiological activities, including cell division, blood vessel formation, and tumor development.

Usage Of Resihance 40 Mg

It is used to treat specific types of advanced or metastatic cancers when other treatments have not been effective. The primary conditions it treats include:

Metastatic Colorectal Cancer (CRC): Regorafenib is used in patients with colorectal cancer that has spread to other parts of the body and is no longer responding to standard chemotherapy.

Gastrointestinal Stromal Tumors (GIST): It is prescribed for patients with advanced GIST, a type of tumor affecting digestive Problems, particularly when previous treatments like imatinib and sunitinib have failed.

Hepatocellular Carcinoma (HCC): Regorafenib is used in treating liver cancer, particularly in patients who have been previously treated with sorafenib, another targeted cancer therapy.

Read More..